Keyphrases
Prognostic Utility
100%
Epidermal Growth Factor Receptor
100%
Endometrial Adenocarcinoma
100%
Receptor Overexpression
100%
Immunoreactivity
37%
Histological Grade
37%
Metastasis
25%
Myometrial Invasion
25%
Overexpression
12%
Endometrial Cancer
12%
Oncoprotein
12%
Protein Level
12%
Clear Cell
12%
Significant Predictors
12%
Logistic Regression Analysis
12%
Bivariate Analysis
12%
Survival Data
12%
Polyclonal Antibody
12%
Neoplastic Cells
12%
Membrane Glycoproteins
12%
Survival Prediction
12%
Prognostic Indicator
12%
Cytoplasmic Membrane
12%
Medical Charts
12%
Analytic Study
12%
Endometrioid
12%
Papillary Serous
12%
Non-endometrioid
12%
Glycoprotein Receptors
12%
Significant Markers
12%
Medicine and Dentistry
Endometrium Carcinoma
100%
Epidermal Growth Factor Receptor
100%
Immunoreactivity
37%
Metastatic Carcinoma
25%
Receptor
12%
Clear Cell
12%
Membrane Protein
12%
Logistic Regression Analysis
12%
Multivariate Logistic Regression Analysis
12%
Polyclonal Antibody
12%
Oncoprotein
12%
Bivariate Analysis
12%
Uterine Cancer
12%
Nursing and Health Professions
Endometrium Carcinoma
100%
Epidermal Growth Factor Receptor
100%
Endometrium Cancer
12%
Membrane Protein
12%
Bivariate Analysis
12%
Logistic Regression Analysis
12%
Multivariate Logistic Regression Analysis
12%
Receptor
12%
Polyclonal Antibody
12%
Oncoprotein
12%
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Carcinoma
100%
Epidermal Growth Factor Receptor
100%
Receptor
12%
Endometrium Cancer
12%
Membrane Protein
12%
Polyclonal Antibody
12%
Oncoprotein
12%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Immunoreactivity
37%
Membrane Protein
12%
Polyclonal Antibody
12%
Veterinary Science and Veterinary Medicine
Epidermal Growth Factor
100%